TrialBMJ open2022

Randomised placebo-controlled multicentre trial to evaluate the efficacy and safety of JTR-161, allogeneic human dental pulp stem cells, in patients with Acute Ischaemic stRoke (J-REPAIR).

Satoshi Suda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.